Bcl-2 Slowsin VitroBreast Cancer Growth Despite Its Antiapoptotic Effect

This publication has 19 references indexed in Scilit:

• The proto-oncogene Bcl-2 and its role in regulating apoptosis
  Nature Medicine, 1997
• Follicular large-cell lymphoma treated with intensive chemotherapy: an analysis of 89 cases included in the LNH87 trial and comparison with the outcome of diffuse large B-cell lymphoma. Groupe d'Etude des Lymphomes de l'Adulte.
  Journal of Clinical Oncology, 1997
• REGULATION OF CLINICAL CHEMORESISTANCE BY bcl‐2 AND BAX ONCOPROTEINS IN B‐CELL CHRONIC LYMPHOCYTIC LEUKAEMIA
  British Journal of Haematology, 1996
• Expression of Bcl-2 in node-negative breast cancer is associated with various prognostic factors, but does not predict response to one course of perioperative chemotherapy
  British Journal of Cancer, 1996
• Prognostic value of bcl-2 expression in invasive breast cancer
  British Journal of Cancer, 1995
• bcl‐2, a novel reguator of cell death
  BioEssays, 1995
• Apoptosis in cancer therapy: Crossing the threshold
  Cell, 1994
• Apoptosis. Its significance in cancer and cancer Therapy
  Cancer, 1994
• bcl-2 in normal human breast and carcinoma, association with oestrogen receptor-positive, epidermal growth factor receptor-negative tumours and in situ cancer
  British Journal of Cancer, 1994
• BCL2 protein is topographically restricted in tissues characterized by apoptotic cell death.
  Proceedings of the National Academy of Sciences, 1991